Alvotech moves to bring its Humira biosimilar to US market
The long-term agreement will see increased access of Simlandi, a biosimilar to AbbVie’s Humira, in the US market.
The long-term agreement will see increased access of Simlandi, a biosimilar to AbbVie’s Humira, in the US market.
For the process, the researchers employed a machine learning method called transfer learning.
The pharmaceutical industry continues to be a hotbed of patent innovation. Activity is driven by the evolution of treatment paradigms,...
TetraScience and Google Cloud link for AI-driven drug developments
Bayer and Google Cloud to develop AI solutions for radiologists
Q&A: BARDA wants to back tech that can combat multiple infections, says director
Can pharma overcome generative AI’s bias problem?